| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医疗健康服务(元) | 6,672,000,000.00 | 3,130,000,000.00 | 6,080,000,000.00 | 2,918,000,000.00 |
| 医学诊断与医疗器械(元) | 4,390,000,000.00 | 2,218,000,000.00 | 6,949,000,000.00 | 4,043,000,000.00 |
| 制药(元) | 30,222,000,000.00 | 15,995,000,000.00 | 30,812,000,000.00 | 14,327,000,000.00 |
| 营业成本(元) | ||||
| 医疗健康服务(元) | 5,231,000,000.00 | 2,484,000,000.00 | 4,945,000,000.00 | 2,402,000,000.00 |
| 医学诊断与医疗器械(元) | 2,201,000,000.00 | 1,052,000,000.00 | 4,289,000,000.00 | 2,650,000,000.00 |
| 制药(元) | 14,090,000,000.00 | 7,115,000,000.00 | 13,840,000,000.00 | 6,509,000,000.00 |
| 毛利(元) | ||||
| 医疗健康服务(元) | 1,441,000,000.00 | 646,000,000.00 | 1,135,000,000.00 | 516,000,000.00 |
| 医学诊断与医疗器械(元) | 2,189,000,000.00 | 1,166,000,000.00 | 2,660,000,000.00 | 1,393,000,000.00 |
| 制药(元) | 16,132,000,000.00 | 8,880,000,000.00 | 16,972,000,000.00 | 7,818,000,000.00 |
| 毛利率(%) | ||||
| 医疗健康服务(%) | 21.60 | 20.64 | 18.67 | 17.68 |
| 医学诊断与医疗器械(%) | 49.86 | 52.57 | 38.28 | 34.45 |
| 制药(%) | 53.38 | 55.52 | 55.08 | 54.57 |
| 收入构成(%) | ||||
| 医疗健康服务(%) | 16.16 | 14.67 | 13.87 | 13.71 |
| 医学诊断与医疗器械(%) | 10.63 | 10.39 | 15.85 | 18.99 |
| 制药(%) | 73.21 | 74.94 | 70.28 | 67.30 |
| 毛利构成(%) | ||||
| 医疗健康服务(%) | 7.29 | 6.04 | 5.47 | 5.30 |
| 医学诊断与医疗器械(%) | 11.08 | 10.91 | 12.81 | 14.32 |
| 制药(%) | 81.63 | 83.05 | 81.73 | 80.37 |